• Organizer
  Hyuk Sang Yoo
  Kangwon National University, Korea, Republic of
  Hyuk Sang Yoo
  Kangwon National University, Korea, Republic of

  He received a B.S. degree (1996), a M.S. degree (1998), and a Ph.D. degree (2002, Advisor: Professor Tae Gwan Park) at Department of Biological Sciences, Korea Advanced Institute of Science and Technology. After a post-doctoral fellow at Department of Biomedical Engineering, the Johns Hopkins University (2004, Advisor: Professor Kam W. Leong), he joined the Kangwon National University as an assistant professor (2005). He is now a tenured professor of Biomedical Materials Engineering. He was also a visiting scholar for the Johns Hopkins University (2005) and the Northwestern University (2010). His research is focused on nano-biomaterials for drug delivery and tissue engineering employing multifunctional nanofibers and nanoparticles.
  Http://nano-bio.kangwon.ac.kr
• Chair
  Hyuk Sang Yoo
  Kangwon National University, Korea, Republic of
  Hyuk Sang Yoo
  Kangwon National University, Korea, Republic of

  He received a B.S. degree (1996), a M.S. degree (1998), and a Ph.D. degree (2002, Advisor: Professor Tae Gwan Park) at Department of Biological Sciences, Korea Advanced Institute of Science and Technology. After a post-doctoral fellow at Department of Biomedical Engineering, the Johns Hopkins University (2004, Advisor: Professor Kam W. Leong), he joined the Kangwon National University as an assistant professor (2005). He is now a tenured professor of Biomedical Materials Engineering. He was also a visiting scholar for the Johns Hopkins University (2005) and the Northwestern University (2010). His research is focused on nano-biomaterials for drug delivery and tissue engineering employing multifunctional nanofibers and nanoparticles. Http://nano-bio.kangwon.ac.kr
• Co-chair
  Katja Schenke-Layland
  Eberhard Karls University Tubingen, Germany
  Katja Schenke-Layland
  Eberhard Karls University Tubingen, Germany

  Katja Schenke-Layland is the Professor of Medical Technologies and Regenerative Medicine at the Medical Faculty of the University Tübingen (MFT). She is the Director of the NMI Natural and Medical Sciences Institute in Reutlingen, the CEO of the NMI-TT GmbH, and the Study Dean of Medical Technologies at the University of Tübingen. Katja is currently the Co-Editor-In-Chief of Tissue Engineering Part B (Mary Ann Liebert) and Executive Editor of Advanced Drug Delivery Reviews (Elsevier), as well as on several editorial boards such as Matrix Biology (Elsevier), Current Opinion in Biomedical Engineering (Elsevier), and Journal of 3D Printing in Medicine (Future Medicine). Katja is a fellow/ board member of the German National Academy of Science and Engineering (acatech), the German Central Ethics Committee for Stem Cell Research (ZES), International and German Societies of Matrix Biology, and the European Alliance for Medical and Biological Engineering and Science (EAMBES). She has published more than 190 peer-reviewed articles, has an h-index of 51 (Scopus), and has been granted 4 patents.
• Invited Speaker
  12:20~12:28
  Kam W. Leong
  Columbia University, USA
  Presentation Title : Biomaterials
• Invited Speaker
  12:28~12:36
  Katja Schenke-Layland
  Eberhard Karls University Tubingen, Germany
  Presentation Title : Tissue Engineering Part C
  Katja Schenke-Layland
  Eberhard Karls University Tubingen, Germany

  Katja Schenke-Layland is the Professor of Medical Technologies and Regenerative Medicine at the Medical Faculty of the University Tübingen (MFT). She is the Director of the NMI Natural and Medical Sciences Institute in Reutlingen, the CEO of the NMI-TT GmbH, and the Study Dean of Medical Technologies at the University of Tübingen. Katja is currently the Co-Editor-In-Chief of Tissue Engineering Part B (Mary Ann Liebert) and Executive Editor of Advanced Drug Delivery Reviews (Elsevier), as well as on several editorial boards such as Matrix Biology (Elsevier), Current Opinion in Biomedical Engineering (Elsevier), and Journal of 3D Printing in Medicine (Future Medicine). Katja is a fellow/ board member of the German National Academy of Science and Engineering (acatech), the German Central Ethics Committee for Stem Cell Research (ZES), International and German Societies of Matrix Biology, and the European Alliance for Medical and Biological Engineering and Science (EAMBES). She has published more than 190 peer-reviewed articles, has an h-index of 51 (Scopus), and has been granted 4 patents.
• Invited Speaker
  12:36~12:44
  Fan Yang
  Stanford University School of Medicine, USA
  Presentation Title : ACS Biomaterials Science and Engineering
  Fan Yang
  Stanford University School of Medicine, USA

  Fan Yang is an Associate Professor with tenure at Stanford University with joint appointments in the Departments of Bioengineering and Orthopaedic Surgery, and Director of Stanford Stem Cells and Biomaterials Engineering Laboratory. Her research seeks to develop hydrogels with unique design at micro- and nano- scales to modulate stem cell differentiation, tissue regeneration and immunomodulation, with applications focus on musculoskeletal diseases. Her lab also harnesses biomaterials to create 3D cancer models with in vivo-mimicking phenotype and drug responses. Such 3D models could enable discovering novel druggable targets that would otherwise be missed using conventional 2D culture, and enable high-throughput drug screening with reduced cost and time than animal models. Prior to joining Stanford, Dr. Yang received her Ph.D. in Biomedical Engineering from Johns Hopkins University, and then completed a postdoctoral fellowship at MIT under Prof. Robert Langer. In recognition of her innovation, she has been recognized by numerous awards including Fellow of American Institute for Medical and Biological Engineering, MIT TR35 Global list honoree, National Science Foundation CAREER award, Young Investigator Award from Society for Biomaterials, Biomaterials Science Lectureship Award, Young Investigator award from Alliance for Cancer and Gene Therapy, Ellen Weaver Award by the Association for Women in Science, Baxter Faculty Scholar Award, the McCormick Faculty Award, Stanford Asian American Faculty Award, and the Basil O’Connor Starter Scholar Research Award.
• Invited Speaker
  12:44~12:52
  Byeongmoon Jeong
  Ewha Womans University, Korea, Republic of
  Presentation Title : Biomaterials Research
  Byeongmoon Jeong
  Ewha Womans University, Korea, Republic of

  Byeongmoon Jeong received his B.S. (1987) in the Department of Chemistry from Seoul National University, M.S (1989) from KAIST, and his Ph.D. (1999) in the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah. He worked at the Pacific Northwest National Laboratory, USA as a senior research scientist before joining Ewha Womans University in 2002. He has authored 150 international peer-reviewed papers and patents on stimuli-sensitive polymers; particularly related to biodegradable thermogels. His publications have been cited 17,000 times during the last decade. He received an Achievement Award in the Polymer Division of Korean Chemical Society (2010), Hanwha Polymer Award from Polymer Society of Korea (2021), Osstem Implant Biomaterials Grand Prize from Korean Society for Biomaterials (KSBM) (2022). His research concentrates on stimuli-sensitive hydrogels and their applications for drug delivery and tissue engineering. He is also serving as vice president of KSBM and editor in cheif of Biomaterials Research, an official journal of KSBM.
• Invited Speaker
  12:52~13:00
  Michaela Muehlberg
  Royal Society of Chemstry (RSC), United Kingdom
  Presentation Title : Journal of Materials Chemistry (JMC) A/B/C
  Michaela Muehlberg
  Royal Society of Chemstry (RSC), United Kingdom

  Dr Michaela Muehlberg is Executive Editor for the RSC’s Materials & Nano portfolio including Materials Horizons, Journals of Materials Chemistry A, B and C, Nanoscale Horizons and Nanoscale. She has been with the Royal Society of Chemistry since 2014 working on a variety of RSC journals including RSC Advances, Chemical Communications and Organic & Biomolecular Chemistry. Previous to that she studied chemistry at the Free University of Berlin, Germany and Université Paris-Sud, France, and obtained a PhD in bioorganic chemistry from the Free University of Berlin, Germany.

This forum provides an opportunity for participants to engage with editors from prominent publications specializing in the disciplines of biomaterials, tissue engineering, and biomedical engineering. The editors provide a concise overview of three key aspects of the journal: 1) its scopes and purposes, 2) the peer review process and policy, and 3) the latest statistics pertaining to peer review and citation. Subsequently, all participants proceed to pose their queries to the editors concerning the procedures for submitting manuscripts and the subsequent review process. Therefore, this session has the potential to address several significant challenges and misunderstandings that arise during the review process of these core journals in the respective research domains. Additionally, it can enhance effective communication between the editorial teams and authors who contribute to these journals.

Keywrod : Editors

• Invited Speaker
  12:20~12:45
  Inhae Shin
  Human Materials R&D Team, Korea, Republic of
  Presentation Title : Overview of Compact bone grafting and absorptive membranes
• Invited Speaker
  In Bo Han
  CHA Univ. School of Medicine, Korea, Republic of
  Presentation Title : Hemostatic efficacy and safety of CollaStat in a spinal surgery
  In Bo Han
  CHA Univ. School of Medicine, Korea, Republic of

  Dr. Inbo Han, M.D., Ph.D., is a distinguished figure in the field of neurosurgery and regenerative medicine. A proud alumnus of Yonsei University, Dr. Han further honed his expertise through a research fellowship at the esteemed Spinal Cord Injury and Stem Cell Biology Laboratory, Brigham and Women's Hospital/Harvard Medical School, USA, from 2010 to 2012. Her formative years also included a residency at Yonsei University Severance Hospital between 1997 and 2002. Dr. Han's career progressed through various roles of increasing responsibility and impact. He has served with distinction as both an assistant and associate professor of neurosurgery at Bundang CHA Medical Center. In his current role, Dr. Han not only excels as a professor of neurosurgery but also contributes significantly as the vice dean of research director at CHA University, School of Medicine, and a director of the Advanced regenerative medicine center for Future Medicine. Dr. Han has garnered widespread recognition for her pioneering research in regenerative therapies targeting incurable spinal diseases. His contributions to the field are evidenced by a slew of outstanding publications and a multitude of prestigious awards. Additionally, he plays a pivotal role in the Society of Neurosurgery and the Society for Regenerative Basic Science, further cementing his status as a leading authority in his field.

Company Seminar 2 (Dalim Tissen)

During spinal surgery, it is important to achieve accurate and rapid haemostasis to reduce operation and anaesthesia time and maintain patients’ haemodynamic equilibrium, in order to decrease the occurrence of complications. CollaStat, a thrombin-containing collagen-based topical hemostatic agent, is a paste-like flowable hemostatic matrix which exhibits both passive and active blood coagulation mechanisms of action. Collagen granules of CollaStat have a physical compression effect by swelling up on contact with blood, and act as a matrix for fibrin clot formation. And the thrombin triggers the biological reaction which initiates the innate coagulation cascade while collagen supports complete activation and adhesion of platelets. CollaStat is ready to be used within 60 seconds by a simple preparation step comprising of syringe connecting and mixing, without a time-consuming thrombin reconstitution step. This simple preparation step of CollaStat may significantly reduce the preparation time compared with those of other flowable hemostats, which require an additional thrombin reconstitution step. Furthermore, flowable characteristics of CollaStat facilitated its application in irregular and small spaces, filling deep lesions, and removing excessive material by irrigation. As demonstrated in various clinical studies, CollaStat was shown to have rapid, safe, and effective hemostasis in spinal surgery.

Keywrod : DENTIS, Dalim Tissen

• Organizer
  Seung-Woo Cho
  Yonsei University, Korea, Republic of
  Seung-Woo Cho
  Yonsei University, Korea, Republic of

  Seung-Woo Cho is a professor at the Department of Biotechnology at Yonsei University, Republic of Korea. He obtained his B.S.,M.S., and Ph.D. degrees at the School of Chemical Engineering of Seoul National University in 1999, 2001, and 2006, respectively. He received his postdoctoral training at the Department of Chemical Engineering in the Massachusetts Institute of Technology. He later joined Yonsei University as a faculty member in 2010 and has been appointed as Underwood Distinguished
  Professor since 2020. His research interests include engineering stem cells, reprogrammed cells, and organoids with functional biomaterials and devices for tissue engineering, disease modeling, and drug screening.
• Chair
  Shelly Sakiyama-Elbert
  University of Washington, USA
  Shelly Sakiyama-Elbert
  University of Washington, USA

  Shelly Sakiyama-Elbert, Ph.D. is the Vice Dean for Research and Graduate Education in the University of Washington School of Medicine and Professor of Bioengineering. She earned a S.B. in chemical engineering and biology from Massachusetts Institute of Technology, and a M.S. and Ph.D. from California Institute of Technology. She joined the faculty at Washington University in Biomedical Engineering in 2000 as an Assistant Professor, where she advanced to the position of the Joseph and Florence Farrow Professor of Biomedical Engineering and Vice Dean for Research in the School of Engineering. She served as Department Chair and Professor of Biomedical Engineering at the University of Texas at Austin from 2016- 2022. Her research program focuses on developing biomaterials for drug delivery and cell transplantation for the treatment of peripheral nerve and spinal cord injury. She was Co-Director of the Center of Regenerative Medicine, as well as a member of the Institute of Materials Science and Engineering at Washington University. Her honors include Senior Scientist Award -TERMIS AM (2023), Fellow of the National Academy of Inventors (2017), Society for Biomaterials Clemson Award for Basic Research (2017), Outstanding Faculty Mentor from the WU Graduate Student Senate (2015), WU Distinguished Faculty Award (2013), and WU Dean’s Award for Excellence in Advising and Mentoring (2008). She was elected Fellow of the International College of Fellows in Biomaterials Science and Engineering in 2016, the American Association for the Advancement of Science (AAAS) in 2015, the Biomedical Engineering Society (BMES) in 2013, and the and the American Institute for Medical and Biological Engineering (AIMBE) in 2011.
• Co-chair
  Yoonhee Jin
  Yonsei University, Korea, Republic of
• Invited Speaker
  12:20~12:35
  Hala Zreiqat
  University of Sydney, Australia
  Presentation Title : Strength in Diversity: A BioEngineering Journey
  Hala Zreiqat
  University of Sydney, Australia

  Hala Zreiqat, is a Payne-Scott Professor of biomedical engineering at The University of Sydney. The focus of her lab is on engineering functional synthetic biomaterials for use in regenerative medicine using cutting-edge materials, biological and nano techniques, and novel 3D-printing technologies. Prof. Zreiqat’s contribution to regenerative medicine and orthopaedic research has led to a number of national and international awards, including being named a Member of the Order of Australia (2019), 2021-2022 Fulbright Senior Scholar; Laureate for the TAKREEM Foundation 2022 “Scientific & Technological Achievement”; the 2018 New South Wales Premier’s Woman of the Year, the King Abdullah II Order of Distinction of the Second Class (2018), Radcliffe Fellow at Harvard University (2016-2017); Eureka Prize winner for Innovative Use of Technology (2019); and University of Sydney Payne-Scott Professorial Distinction (2019). She is also a Fellow of the Australian Academy of Sciences (2021); the Australian Academy of Technology & Engineering (2020), the International Association of Advanced Materials (2022), the Royal Society of New South Wales (2019); Australian Academy of Health and Medical Sciences (2019), and the International Orthopaedic Research Society (2019). She is the past president of the Australian & New Zealand Orthopaedic Research Society. She was the Director of the Australian Research Council Training Centre for Innovative BioEngineering (2017-2022) and a National Health and Medical Research Council Senior Research Fellow (2006-2020). She is the Chair of the Council for Australian-Arab Relations (CAAR) (2020-2023); an Associate of the John A. Paulson School of Engineering and Applied Sciences at Harvard University and an Honorary Professor at Shanghai Jiao Tong University. Prof. Zreiqat has authored over 180 peer-reviewed publications with over 10,000 citations. Her research in the field of musculoskeletal disorders and biomaterials research has led to four awarded and four provisional patents and more than $20.5M in competitive funding, including major grants from the National Health and Medical Research Council, Australian Research Council and the New South Wales Medical Devices Fund. As well as her pioneering work in biomaterials development, Prof. Zreiqat is committed to improving opportunities for women and young scientists around the world. She is the founder and Chair of the BIOTech Futures, a science and engineering mentorship program for high school students.
• Invited Speaker
  12:35~12:50
  Sung Yun Yang
  Chungnam National University, Korea, Republic of
  Presentation Title : Past, Present, and Future States of Korean Woman Scientists in Korean Biomaterials Research Society
  Sung Yun Yang
  Chungnam National University, Korea, Republic of

  Sung Yun Yang received her B.S and M.S. from Ewha Womans University in 1991 and 1993, respectively. After serving in the Chemistry division at KRICT and KIST, in 1995 moved to USA for her doctoral degree in Polymer Chemistry and Engineering at Polytechnic University, New York University currently. In August of 2000, she moved to MIT as a postdoctoral researcher in the Department of Materials Science and Engineering. She worked in a biotech company for a year and returned to Korea in 2004 starting her professorship at Chungnam National University. Since 2004 she has been with CNU, is now a professor of Organic Materials Engineering. Along with her research and academic activity, she also served as a vice-president of the Center for Women in Science, Engineering and Technology to promote educational opportunity for woman engineers. Prof. Yang’s research interests include functional nanomaterials for energy, environmental sustainability, and biomedical application.
• Invited Speaker
  12:50~13:05
  Maria Chatzinikolaidou
  Foundation for Research and Technology Hellas (FORTH) Institute of Electronic Structure and Laser 100, Greece
  Presentation Title : A fascinating journey in Biomaterials for Tissue Engineering
  Maria Chatzinikolaidou
  Foundation for Research and Technology Hellas (FORTH) Institute of Electronic Structure and Laser 100, Greece

  Dr. Maria Chatzinikolaidou, FBSE, FTERM, is an Associate Professor of Biomaterials in Bioengineering and Head of the Laboratory for Biomaterials in Tissue Engineering at the Department of Materials Science and Technology at the University of Crete (https://www.materials.uoc.gr/el/general/personnel/mchatzin.html), and affiliated faculty member at Foundation for Research and Technology – Hellas (FORTH). Her research interests focus on the development of biomaterials and scaffolds for tissue engineering applications including bone, dental, cardiovascular, and the validation of their in vitro and in vivo biocompatibility, functionality and biomechanical characteristics. Dr. Chatzinikolaidou is actively involved in several competitive national and international projects, is author of >90 publications in international peer-reviewed journals, 4 book chapters, >180 peer-reviewed conference abstracts, and inventor of 4 patents on osteoinductive implants. She was elected member of the Executive Board of the Hellenic Society for Biomaterials and served as vice president in the terms 2015-2018 and 2022-now. She served as chair of the 28th Conference of the European Society for Biomaterials (ESB 2017) held in Athens, and program chair of the TERMIS-EU 2019 conference held in Rhodes in Greece. She is a Fellow in Biomaterials Science and Engineering (FBSE, elected 2020) of the International Union of Societies for Biomaterials Science and Engineering (IUS-BSE) and International Fellow of Tissue Engineering and Regenerative Medicine (FTERM, elected 2023). Since 2022 she is member of the Nomination Committee of Tissue Engineering and Regenerative Medicine International Society (TERMIS) EU chapter. She is an editorial board member in Tissue Engineering, Frontiers in Bioengineering and Biotechnology, Regenerative Biomaterials, Frontiers in Bioengineering and Biotechnology, Journal of Materials Science Materials in Medicine etc. She teaches lectures on Biomaterials, Cell Biology and Biochemistry, and Tissue Engineering in undergraduate and graduate courses at the University of Crete and other Universities in Grece, and is currently supervisor of four PhD candidates and three Master’s students.

Women play a crucial and influential role, contributing significantly to advancements of the dynamic field of biomaterials research. Nevertheless, a disparity in gender representation has persisted, and this imbalance can be attributed, at least in part, to cultures that lack support and impede the progress of women in their professional endeavors.  This luncheon session will feature a panel of women scientists with diverse perspectives and experiences in the realm of biomaterials research, with brief presentations and discussions focusing on experiences, goals and best practices for effectively addressing barriers for increased diversity and inclusivity in biomaterials research.

• Organizer
  Seung-Woo Cho
  Yonsei University, Korea, Republic of
  Seung-Woo Cho
  Yonsei University, Korea, Republic of

  Seung-Woo Cho is a professor at the Department of Biotechnology at Yonsei University, Republic of Korea. He obtained his B.S.,M.S., and Ph.D. degrees at the School of Chemical Engineering of Seoul National University in 1999, 2001, and 2006, respectively. He received his postdoctoral training at the Department of Chemical Engineering in the Massachusetts Institute of Technology. He later joined Yonsei University as a faculty member in 2010 and has been appointed as Underwood Distinguished
  Professor since 2020. His research interests include engineering stem cells, reprogrammed cells, and organoids with functional biomaterials and devices for tissue engineering, disease modeling, and drug screening.
• Chair
  James Moon
  University of Michigan, Ann Arbor, USA
  James Moon
  University of Michigan, Ann Arbor, USA

  Dr. James Moon is John Gideon Searle Professor in the Department of Pharmaceutical Sciences, Biomedical Engineering, and Chemical Engineering at the University of Michigan, Ann Arbor. His interdisciplinary research program aims to develop novel biomaterials-based strategies to advance fundamental understanding of the immune system, with the ultimate goal of improving patients’ lives with effective vaccines and immunotherapies. Dr. Moon has published over 120 research articles, including those published in Nature Materials, Nature Medicine, Nature Nanotechnology, Nature Biomedical Engineering, Nature Reviews Materials, and Science Translational Medicine. He has over 20 pending/approved U.S. and international patent applications, and his novel nano-vaccine delivery technologies have led to 3 new start-up companies (EVOQ Therapeutics, Saros Therapeutics, and Elicio Therapeutics). Dr. Moon is a fellow of BMES, AIBME, and CRS, and his contributions to the field has been recognized with numerous awards, including NSF CAREER Award and Samyang CRS Award. Dr. Moon received his bachelor’s degree from the University of California, Berkeley (2002), and his Ph.D. from Rice University (2008), and he completed his postdoctoral training at MIT. He joined the faculty of the University of Michigan in 2012.
• Co-chair
  Sing Yian Chew
  Nanyang Technological University, Singapore
  Sing Yian Chew
  Nanyang Technological University, Singapore

  Dr. Sing Yian CHEW is a Professor at the School of Chemistry, Chemical Engineering and Biotechnology, the Lee Kong Chian School of Medicine and the School of Materials Science and Engineering at Nanyang Technological University, Singapore. She is known for her contributions in designing biomimetic scaffolds to understand and control cell fate. Dr. Chew’s most significant contribution is in the field of scaffold-mediated delivery of gene-silencing and biomimicking physical signals for neural tissue regeneration and remyelination. Specifically, her lab engineers bio-functional platforms for long-term delivery of biologics. These scaffolding constructs may be used for understanding and directing neural tissue regeneration after traumatic injuries, stem cell fate and host-implant integration. Since joining NTU, Dr. Chew has continued to embark on scientific learning and exchanges by serving as visiting scholar/professor at Johns Hopkins University, University of Edinburgh, INSERM (U698 and U791); University of Paris 13; University of Nantes; Jinan University in Guangzhou, China; Wyss Institute at Harvard. She is an Associate Editor at ACS Applied Materials & Interfaces. She also serves as the editorial board member of Biomaterials, Experimental Neurology, Tissue Engineering, Journal of Biomedical Materials Research, Part A, Drug Delivery and Translational Research, Journal of Tissue Engineering.
• Speaker
  12:20~12:35
  Elizabeth Cosgriff Hernandez
  University of Texas at Austin, USA
  Presentation Title : My Faculty Odyssey: A Polymer Love Story
  Elizabeth Cosgriff Hernandez
  University of Texas at Austin, USA

  Elizabeth Cosgriff-Hernandez, Ph.D. is a Professor of Biomedical Engineering at The University of Texas at Austin and holder of the Cullen Trust for Higher Education Endowed Professorship in Engineering. She received a B.S. in Biomedical Engineering and Ph.D. in Macromolecular Science and Engineering from Case Western Reserve University and then completed a UT-TORCH Postdoctoral Fellowship at Rice University with a focus in orthopaedic tissue engineering. Dr. Cosgriff-Hernandez joined the faculty of the Biomedical Engineering Department at Texas A&M University in 2007 prior to moving to The University of Texas at Austin in 2017. Her laboratory specializes in the development of polymeric biomaterials to improve clinical outcomes of medical devices and regeneration strategies. She is a co-founder of Rhythio Medical, on the scientific advisory board of ECM Biosurgery, and a consultant to several companies on biostability evaluation of medical devices. Dr. Cosgriff-Hernandez is an Associate Editor of the Journal of Materials Chemistry B and Fellow of the International Union of Societies for Biomaterials Science and Engineering, Biomedical Engineering Society, Royal Society of Chemistry, and the American Institute for Medical and Biological Engineering. She has previously served as an Associate Editor of the Journal of Biomedical Materials Research, Part B and chair of the NIH study section on Musculoskeletal Tissue Engineering.
• Speaker
  12:35~12:50
  Lorenzo Moroni
  Maastricht University, Netherlands
  Presentation Title : High and Low Tides in Science: navigating through the sea with serendipity in a daring adventure
  Lorenzo Moroni
  Maastricht University, Netherlands

  Prof. Dr. Lorenzo Moroni studied Biomedical Engineering at Polytechnic University of Milan, Italy, and Nanoscale Sciences at Chalmers Technical University, Sweden. He received his Ph.D. cum laude in 2006 at University of Twente on 3D scaffolds for osteochondral regeneration, for which he was awarded the European doctorate award in Biomaterials and Tissue Engineering from the European Society of Biomaterials (ESB). In 2007, he worked at Johns Hopkins University as a post-doctoral fellow in the Elisseeff lab, focusing on hydrogels and stem cells. In 2008, he was appointed the R&D director of the Musculoskeletal Tissue Bank of Rizzoli Orthopedic Institute, where he investigated the use of stem cells from alternative sources for cell banking, and the development of novel bioactive scaffolds for skeletal regeneration. From 2009 till 2014, he joined again University of Twente, where he got tenured in the Tissue Regeneration department. Since 2014 he works at Maastricht University, where he is a founding member of the MERLN Institute for Technology-Inspired Regenerative Medicine. In 2016, he became full professor in biofabrication for regenerative medicine. Since 2019, he is chair of the Complex Tissue Regeneration department. He was vice-director of MERLN from 2019 till 2022. Since 2022, he is director of MERLN. His research group interests aim at developing biofabrication technologies to generate libraries of 3D scaffolds able to control cell fate, with applications spanning from skeletal to vascular, neural, and organ regeneration. From his research efforts, 3 products have already reached the market. In 2014, he received the prestigious Jean Leray award for outstanding young principal investigators from the ESB and the ERC starting grant. In 2016, he also received the prestigious Robert Brown Award for outstanding early career principal investigators from TERMIS. In 2017, he was elected as faculty of the Young Academy of Europe and in the top 100 Italian scientists within 40 worldwide by the European Institute of Italian Culture. He has been elected as member of the Science Academy of Europe since 2022.
• Speaker
  12:50~13:05
  Khoon Lim
  University of Sydney, Australia
  Presentation Title : Building a meaningful peer-support network for greater success
  Khoon Lim
  University of Sydney, Australia

  Associate Professor Khoon Lim is currently an Australian Research Council Future Fellow and the Director of the Light Activated Biomaterials research group at the University of Sydney, Australia. Khoon is a biomedical engineer with specialization in polymer chemistry. He completed a concurrent degree - Bachelors (Hons 1) in Chemical Engineering and Masters in Biomedical Engineering, followed by a PhD in Biomedical Engineering (graduated 2014) from the University of New South Wales. He then went to join the Department of Orthopedic Surgery and Musculoskeletal Medicine at the University of Otago Christchurch in New Zealand for a postdoctoral fellowship, where he established the Light Activated Biomaterials (LAB) research group in 2019. In 2022, he joined the University of Sydney. His research focus is on adopting a class of polymers known as hydrogels as tissue engineering matrices for a variety of applications. His has developed a number of research technology platform, primarily using photo-polymerizable hydrogel bioinks for 3D bioprinting of functional tissues and also delivery of bioactive molecules to promote tissue regeneration. He has generated multiple high impact journal publications (Chemical Reviews, Advanced Materials, Advanced Functional Materials), and raised a total of >$7.8 Million research grant funding with $5.4 Million as lead Chief-Investigator. He has won >20 competitive national/international awards and included in the World’s Top 2% Scientist List by Stanford University for 2022 and 2023. His research has also led to commercialisation of biomaterials licensed to a US-based company and commercial contracts with industry partners. His research has also generated a number of intellectual property and patent applications, including a full utility patent now granted in China, Australia, America and Europe, where he’s the lead inventor. He is also involved in a number of collaborative projects involving national and international collaborators (Germany, Netherlands, Australia, China and Scotland). He is the current President of the Australasian Society for Biomaterials and Tissue Engineering, Board Member of the International Society for Biofabrication, and Executive Board Member of the New Zealand Medical Technology Research Acceleration Programme. He also serves on a number of editorial boards including RSC Biomaterials Science, Biofabrication, Macromolecular Bioscience, International Journal of Bioprinting, Tissue Engineering: Part B, Biomedical Physics and Engineering Express and Journal of Materials Science: Materials in Medicine.

This luncheon session aims to provide scientists and young investigators in Biomaterials research with the necessary tools and knowledge to enhance their professional careers. The session will address topics such as effective writing and publishing strategies, for participants to gain practical knowledge on crafting impactful research papers, understanding the peer-review process, and increasing their visibility within the scientific community. Furthermore, the importance of communication skills is discussed as a key component, with emphasizing the ability to effectively articulate intricate scientific topics and to captivate a wide range of audiences. A significant focus is also placed regarding on the shift to faculty positions in academia. Experienced mentors will share their insights, offering guidance on navigating the academic job market, preparing compelling applications, and excelling in faculty roles for a successful academic career.

• Invited Speaker
  12:20~12:45
  Terance Hart
  Maverick Biosciences, United Kingdom
  Presentation Title : Telocollagen additives for Regenerative Medicine seen through a Dental Device Lens
  Terance Hart
  Maverick Biosciences, United Kingdom

  Dr Hart worked for over 30 years in Pharmaceutical Research for global companies such as Sanofi-Genzyme and Novartis as well as in many different Biotech companies, where he led teams in their discovery of new pharmaceuticals. During the last 14 years he was for 10 years Chief Scientific Officer for Geistlich Pharma in Switzerland, where the R&D team brought through important, innovative collagen based products to the dental and tissue regeneration market, including Mucograft, Fibro-Gide and Derma-Gide. Currently he is a Scientific Advisor for Maverick Bioscience and a member of their Scientific Advisory Board.
• Invited Speaker
  12:45~13:10
  Carlos Carvalho
  Desktop Health™, Germany
  Presentation Title : Designing patterns for tubular scaffolds using the 3D-Bioplotter’s PrintRoll system
  Carlos Carvalho
  Desktop Health™, Germany

  Carlos Carvalho is the Team Leader of the Bioprinting Department at EnvisionTEC GmbH, part of the Desktop Health brand. During his PhD at the University of Freiburg, he co-authored 20 papers centered on the newly invented 3D-Bioplotter in cooperation with several german medical institutes. He contributed significant feedback to assist in the early development of the 3D-Bioplotter technology while using the first three generations of this bioprinter. Recognized for his expertise, he was invited to join EnvisionTEC to develop the 4th generation of the 3D-Bioplotter from a user-centric perspective. Under his leadership, the 3D-Bioplotter has seen continuous advancements in both hardware and software, maintaining its status for over two decades as the preferred bioprinter for academia and industry alike.

Company Seminar 1 (MAVERICK)

Telocollagen additives for Regenerative Medicine seen through a Dental Device Lens
Collagen represents 30% of the protein found in the human body and is the most abundant structural protein in the extracellular matrix, being mainly found in connective tissue such as cartilage, bones, tendons, ligaments, and skin. It contributes much to the ease of handling, formability, and volume stability in many major bone graft substitute products, which are typically based on the natural combination of mineral hydroxyapatite with collagen type I. Fibroblasts produce 28 different types of collagen, each consisting of a linear sequence of amino acids connected to form a highly stable triple helix and each with its own specific biological function. In addition, through its highly evolved cell recognition properties collagen greatly accelerates bone formation, wound healing, and tissue regeneration. The advantages of using xenogenic collagen are manifold, including sustainable supply, usability, biocompatibility, biodegradability, low immunogenicity, cellular porosity and, most importantly, regulatory acceptability. As a consequence, collagen-based products are widely used in all aspects of tissue engineering. This lecture will review the functional biological properties of collagen, its current commercial use, and the future perspectives of collagen-based products in bone and tissue regeneration. 

Company Seminar 2 (Desktop Health™)

Designing patterns for tubular scaffolds using the 3D-Bioplotter’s PrintRoll system
The process for the preparation of scaffold fabrication using a bioprinter is well established. Starting from STL or 3MF files, these can be loaded onto the bioprinter’s software, sliced into layers, and a pre-programmed pattern can be applied to the layers using the technician’s input to meet specific mechanical or biological requirements. These parts can then be printed either onto flat substrates (plastic films, well plates, petri dishes, etc.) or in buoyancy-providing baths.
Nevertheless, this method poses great restrictions on the fabrication of porous tubular scaffolds. Most academic users will print a flat scaffold and roll them into the necessary cylindrical shape, fusing the ends together.
Desktop Health has recently released the PrintRoll upgrade for its modular bioprinter, the 3D-Bioplotter. This platform attachment allows the user to print directly onto a rotating stainless-steel mandrel, available in different diameters. Tubular scaffolds fabricated on the 3D-Bioplotter with PrintRoll can have complex patterns, bestowing them with different mechanical properties like stretchability, compressibility, flexibility, bendability, and shrinkage, as well as biological characteristics.
In this lecture the process for designing these complex patterns using the Desktop Health’s 3D-Bioplotter’s software will be presented.

• Organizer
  Rui Reis
  3B's Research Group/Univ. Minho, Portugal
  Rui Reis
  3B's Research Group/Univ. Minho, Portugal

  Rui L. Reis, PhD, DSc, Hon. Causa MD, Hon Causa PhD, FBSE, FTERM, member of NAE, FAIMBE, FEAMBES, is a Full Professor of Tissue Engineering, Regenerative Medicine, Biomaterials and Stem Cells at University of Minho (UMinho), Portugal. He is the Founding Director of the 3B’s Research Group and Dean/President of the I3Bs – Institute for Biomaterials, Biodegradables and Biomimetics at UMinho. He is also the CEO of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine and has been the Global President of the Tissue Engineering and Regenerative Medicine International Soc. (TERMIS). He is Associate Editor of PNAS-NEXUS and is in the Editorial Board of several other relevant journals. He co-founded several companies that raised important private investments. His work has been cited more than 98000 times and he is listed in the annual Highly Cited Researchers 2022 and 2023 list from Clarivate. He has been awarded many important international prizes.
• Chair
  Rui Reis
  3B's Research Group/Univ. Minho, Portugal
  Rui Reis
  3B's Research Group/Univ. Minho, Portugal

  Rui L. Reis, PhD, DSc, Hon. Causa MD, Hon Causa PhD, FBSE, FTERM, member of NAE, FAIMBE, FEAMBES, is a Full Professor of Tissue Engineering, Regenerative Medicine, Biomaterials and Stem Cells at University of Minho (UMinho), Portugal. He is the Founding Director of the 3B’s Research Group and Dean/President of the I3Bs – Institute for Biomaterials, Biodegradables and Biomimetics at UMinho. He is also the CEO of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine and has been the Global President of the Tissue Engineering and Regenerative Medicine International Soc. (TERMIS). He is Associate Editor of PNAS-NEXUS and is in the Editorial Board of several other relevant journals. He co-founded several companies that raised important private investments. His work has been cited more than 98000 times and he is listed in the annual Highly Cited Researchers 2022 and 2023 list from Clarivate. He has been awarded many important international prizes.
• Invited Speaker
  12:30~12:40
  Milica Radisic
  University of Toronto, Canada
  Presentation Title : For the proposition team
  Milica Radisic
  University of Toronto, Canada

  Dr. Milica Radisic is a Professor at the University of Toronto, Tier 1 Canada Research Chair in Organ-on-a-Chip Engineering and a Senior Scientist at the Toronto General Research Institute. She is also Director of the NSERC CREATE Training Program in Organ-on-a-Chip Engineering & Entrepreneurship and a co-lead for the Center for Research and Applications in Fluidic Technologies. She is a Fellow of the Royal Society of Canada-Academy of Science, Canadian Academy of Engineering, the American Institute for Medical & Biological Engineering, Tissue Engineering & Regenerative Medicine Society as well as Biomedical Engineering Society. She was a recipient of the MIT Technology Review Top 35 Under 35, Queen Elizabeth II Diamond Jubilee Medal, NSERC E.W.R Steacie Fellowship, YWCA Woman of Distinction Award, Killam Fellowship, Acta Biomaterialia Silver Medal, and Humboldt Research Award to name a few. Her research focuses on organ-on-a-chip engineering and development of new biomaterials that promote healing and attenuate scarring. She developed new methods to mature iPSC derived cardiac tissues using electrical stimulation. She is an Executive Editor for ACS Biomaterials Science & Engineering, Senior Consulting Editor for the Journal of Molecular and Cellular Cardiology, a reviewing editor for eLife and a member of the editorial board of another 8 journals. She served on the Board of Directors for Ontario Society of Professional Engineers, Canadian Biomaterials Society and McMaster University Alumni Association. She organized Keystone, EMBO and ECI conferences and numerous sessions at TERMIS and BMES meetings. She served as a Scientific Officer for the Canadian Institutes of Health Research and member of review panels for CIHR, NIH and Israel Ministry of Education. She is the Chair of Investment Committee for Serbia Innovation Fund. She is a co-founder of two companies TARA Biosystems (acquired by Valo Health), that uses human engineered heart tissues in drug development and safety testing, and Quthero that advances regenerative hydrogels. Her work has been presented in over 260 publications, garnering over 20,000 citations with an h-index of 71. Her publications appeared in Cell, Nature Materials, Nature Methods, Nature Protocols, Nature Communications, PNAS etc.
• Invited Speaker
  12:40~12:50
  Changyou Gao
  Zhejiang University, China
  Presentation Title : For the proposition team
  Changyou Gao
  Zhejiang University, China

  Changyou Gao graduated from Department of Chemistry, Jilin University to get his Bachelor degree (1990), Master degree (1993) and Ph.D of Polymer Chemistry and Physics (1996). From 1996 to 1998, he worked in Department of Polymer Science and Engineering of Zhejiang University as a postdoctor fellowship. He was a DAAD and visiting scholar in Germany (1999). He is a Cheung Kong Scholar of Ministry of Education of China, a winner for the National Science Fund for Distinguished Young Scholars of China, a fellow of the international federation of biomaterial science and engineering societies, the American Institute of Medicinal and Biological Engineering, Royal Society of Chemistry, and Chinese Society of Biomaterials. He is now serving as an associate president of Chinese Society of Biomaterials, and an associate editor of Biomaterials Advances and Progress in Materials Science. His research interests include self-adaptive biomaterials, immuno-modulation biomaterials, anti-bacterial biomaterials and their applications in tissue repair and regeneration. He has published more than 500 papers with an H-index of 78.
• Invited Speaker
  12:50~13:00
  Laura Poole-Warren
  The University of New South Wales, Australia
  Presentation Title : For the opposition team
  Laura Poole-Warren
  The University of New South Wales, Australia

  Laura is a Professor in Biomedical Engineering at UNSW and leads a research group focussed on design and development of novel materials for neural electrodes and other soft-tissue interfaces, and on 3D engineered neural tissue models. A key theme of her work is on understanding material and device compatibility with cells and tissues. Throughout her career, she has worked across academia, industry, and government. She was a research professor at the New Jersey Centre for Biomaterials based at Rutgers University in the USA and a preclinical scientist in the biomedical industry working on development of wound dressings and embolic agents for cancer treatment from 1999 to 2001. She also served from 2003 to 2013 as a member of the Australian Government Therapeutic Goods Administration statutory expert committee on the safety of medical devices. Between 2005 and 2018, Laura held various leadership appointments at UNSW as Pro Vice-Chancellor, and Dean of Graduate Research, as well as being the Australian representative on the International Union of Societies of Biomaterials Science and Engineering. She was awarded honours in January 2020 as a Member of the Order of Australia (AM) for service to Biomedical Engineering and education, is a Fellow of three academies, FTSE, FAIMBE and FBSE and the Royal Society of NSW
• Invited Speaker
  13:00~13:10
  Bikramjit Basu
  Indian Institute of Science, Bangalore, India
  Presentation Title : For the opposition team
  Bikramjit Basu
  Indian Institute of Science, Bangalore, India

  Dr. Bikramjit Basu is a Professor at the Indian Institute of Science, Bangalore, India, since 2011 and earlier served on the faculty of the Indian Institute of Technology Kanpur (2001-2011). He has been pursuing research at the confluence of Materials Science, Additive Manufacturing, Biological Science, and Medicine, to address many unanswered questions related to regenerative engineering and reconstructive surgeries. His research group has effectively applied the principles and tools of these disciplines to develop next-generation implants and bioengineering solutions to address unmet clinical needs for musculoskeletal, dental, and neurosurgical applications; thereby impacting human healthcare. His research group has developed technologies related to the manufacturing of bioceramics, acetabular liners, customized bone flaps for cranioplasty surgeries, dental implants and variants of hydrogels. These technologies are transferred to multinational corporates or start-ups, and many of the products, after regulatory clearances, are currently used for patient care in India. A Chartered Engineer of the UK, he has the unique distinction of being the only ceramic scientist from India to get elected to all the major international societies and academies, including the World Academy of Ceramics (2024), the European Ceramic Society (2023), the American Ceramic Society (2019). In India, he is the only engineering scientist to get elected as a Fellow of all the National Academies of Engineering, Science and Medicine, including the Indian National Science Academy (2021), Indian Academy of Sciences (2020), American Ceramic Society (2019), National Academy of Medical Sciences (2017), Indian National Academy of Engineering (2015), and National Academy of Sciences, India (2013). Internationally, he is an elected fellow of the International Union of Societies for Biomaterials Science and Engineering (2020), International Academy of Medical and Biological Engineering (2017) and the American Institute of Medical and Biological Engineering (2015). He is a recipient of India’s most prestigious Science and Technology award, Shanti Swarup Bhatnagar Prize (2013) from the Prime Minister of India; and globally competent awards, like Humboldt Research Award from the Alexander von Humboldt foundation (2022), and International Richard Brook Award from the European Ceramic Society (2022). He is currently serving on many advisory panels of the national institutes, European university and federal funding agencies as well as major multinational corporates. As the current President of the Society for Biomaterials and Artificial Organs India (1000+ members across India, US and Europe) and in his leadership roles as the Chair of Bioceramics Division and other principal committees of the American Ceramic Society (ACerS), he has brought transformative changes to significantly enhance international visibility of the biomaterials programs in different countries, while inspiring several hundreds of young researchers in Bioceramics area across the world. Such activities together with his roles as the lead investigator in several multi-institutional network programs including multicentric clinical studies enabled creating a vibrant translational ecosystem, to bring together key stakeholders (industry professionals and clinicians) on the innovation platform in India.

Motion: "This house believes that organ on a chip and organoids will in the future replace/reduce traditional in-vitro and in-vivo testing in the regulatory approval of biomaterials and drugs”
Chair/moderator: Rui L. Reis, 3B´s Research Group, University of Minho, Portugal, Chair of the Steering Committee of the Fellows in Biomaterials Science and Engineering (FBSE)
- Introduction of the debate rules and to the motion – Rui L. Reis
- For the proposition team
o Milica Radisic (University of Toronto, Canada)
o Changyou Gao (Zhejiang University, China)
- For the opposition team
o Laura Poole-Warren (University of New South Wales, Australia)
o Bikramjit Basu (India Institute of Sciences, India)

Keywrod : FBSE WBC

• Invited Speaker
  LS2-1-1
  In Kwon Jung
  Genoss Co., Ltd., Korea, Republic of
  Presentation Title : Genoss : an innovating company with a variety of advanced medical devices
  In Kwon Jung
  Genoss Co., Ltd., Korea, Republic of

  In Kwon Jung is a former CEO of Genoss Company and currently serves as an advisor. He received his doctorate in polymer biomaterials from Ajou University also over 25 years of medical device industry experience in R&D, manufacturing, RA, quality management, sales, which involved in various vascular interventional devices, synthetic bone grafts, dermal fillers and dental products.

Genoss: an innovating company with a variety of advanced medical devices

Making Invests 30% of the annual revenue in R&D every year, GENOSS has pushed ahead with staffing itself with outstanding research professionals from around the world and developing the world's best products.
Our vision is creating the best products and service for contributing to promotion of human health as a representative of Korean medical device companies. 
GENOSS will develop competitive bioproducts to make them strong players in the global market.
GENOSS will keep focusing on developing medical instruments that fit to the globalization by relying on our willingness to face challenges and also become the world-leading company with innovative value creation through constant R&D on the bio industry.
We promise our growth into the most enterprising company that stands in our global customers’ shoes and values talents, technology and the environment.

Keywrod : Genoss

• Invited Speaker
  12:20~12:45
  Ju Young Park
  BioBricks Co.,Ltd., Korea, Republic of
  Presentation Title : Innovative Tissue Sealants: Advancing Scarless Wound Treatment with X-Pure GelMA
  Ju Young Park
  BioBricks Co.,Ltd., Korea, Republic of

  Dr. Ju Young Park completed her Ph.D. in the Division of Integrative Biosciences & Biotechnology (IBB) at Pohang University of Science and Technology (POSTECH) in 2016. Following her doctoral studies, she worked as a postdoctoral researcher at POSTECH from 2016 to 2019 and then pursued further research training as a postdoctoral research fellow at the Biologically Inspired Engineering Systems Laboratory at the University of Pennsylvania from 2019 to 2022. Dr. Park has made significant contributions to her field, publishing over 30 peer-reviewed papers in prestigious journals within the domains of bioprinting and tissue engineering. Presently, she holds the position of Research Director at Biobricks, a startup company dedicated to tissue engineering utilizing decellularized extracellular matrix materials and 3D bioprinting technologies. In addition to her role at Biobricks, she also serves as a Research Professor in the Department of IT Convergence Engineering at POSTECH. Her research interests are centered around pioneering innovative therapeutic solutions for transplantation within the human body, leveraging stem cells and tissue-derived natural biomaterials, as well as cutting-edge 3D bioprinting technology.
• Invited Speaker
  12:45~13:10
  Paul Delrot
  Readily3D, Switzerland
  Presentation Title : 3D volumetric tomographic bioprinting
  Paul Delrot
  Readily3D, Switzerland

  Paul co-invented the volumetric bioprinting technology at the end of his PhD studies at EPFL in 2017. After transferring what was a lab experiment into a standalone and user-friendly 3D printer, Paul co-founded Readily3D in 2020. Since then, Paul has focused on demonstrating the wide range of applications enabled by volumetric bioprinting while leading product development at Readily3D.

Company Seminar 1 (Rousselot)
Together with POSTECH researchers, BioBricks developed innovative tissue sealants for tissue reconstruction. These novel adhesives combine GelMA and extracellular matrices derived from diverse tissue types, such as cornea, mucosa, liver, and heart, and form solid hydrogels through visible light photocrosslinking. BioBricks tissue sealants integrate well with adjacent tissues, enabling sutureless and scarless treatment of tissue defects or incisions. This breakthrough holds promise for regenerative medicine and tissue reconstruction. The use of medical grade XPure gelMA allows a fast track to market.

Company Seminar 2 (Readily3D)
Tomographic volumetric 3D bioprinting allows building the entire volume of centimer-scale 3D cell- or organoid-laden bioconstructs within less than 30 seconds. This light-based and ultrafast process opens up new opportunities for the biofabrication of complex and functional living constructs thanks to its high viability for both cells and organoids as well as its design freedom.

In recent years, tomographic volumetric bioprinting has for instance been used to build functional hepatic constructs, anatomically correct porous bone models, multi-material perfusable bio-constructs, or even 3D pancreatic cancer models. Thanks to the throughput and repeatability of volumetric bioprinting, such models could be used in a near future for drug development. The scalability of volumetric bioprinting also makes it relevant for regenerative medicine applications.

In this talk, Paul Delrot, PhD, CEO of Readily3D will present the science behind the technology and cover the range of applications enabled by tomographic volumetric 3D bioprinting.

• Organizer
  Jurica Bauer
  Maastricht University, Netherlands
  Jurica Bauer
  Maastricht University, Netherlands

  Dr. Jurica Bauer graduated in chemistry from the University of Zagreb, Croatia, where he developed a passion for research and teaching. Having worked as medicinal chemist at GlaxoSmithKline for a few years, he moved to The Netherlands to pursue a PhD degree in the field of molecular motors and machines with Professor Feringa at the University of Groningen. As a postdoctoral researcher in the group of Professor Broer at the Eindhoven University of Technology and in collaboration with Philips, he developed a smart liquid-crystalline polymer coating for LEDs to fine-tune the properties of emitted light. In 2014 he was appointed Lecturer in Chemistry at the Inholland University of Applied Sciences in Amsterdam where he developed a new Polymer Chemistry minor and acted as graduation and internationalization coordinator. In 2020 he joined the MERLN Institute at the Maastricht University as Assistant Professor of Education to coordinate the design and development of a new undergraduate study program in the field of Regenerative Medicine and Technology. He is also involved in ongoing teaching and research activities within the institute. His interests include innovation and research in STEM education and scientific research in the field of smart, and especially photoresponsive, nanobiomaterials for medicinal applications.
• Chair
  Jurica Bauer
  Maastricht University, Netherlands
  Jurica Bauer
  Maastricht University, Netherlands

  Dr. Jurica Bauer graduated in chemistry from the University of Zagreb, Croatia, where he developed a passion for research and teaching. Having worked as medicinal chemist at GlaxoSmithKline for a few years, he moved to The Netherlands to pursue a PhD degree in the field of molecular motors and machines with Professor Feringa at the University of Groningen. As a postdoctoral researcher in the group of Professor Broer at the Eindhoven University of Technology and in collaboration with Philips, he developed a smart liquid-crystalline polymer coating for LEDs to fine-tune the properties of emitted light. In 2014 he was appointed Lecturer in Chemistry at the Inholland University of Applied Sciences in Amsterdam where he developed a new Polymer Chemistry minor and acted as graduation and internationalization coordinator. In 2020 he joined the MERLN Institute at the Maastricht University as Assistant Professor of Education to coordinate the design and development of a new undergraduate study program in the field of Regenerative Medicine and Technology. He is also involved in ongoing teaching and research activities within the institute. His interests include innovation and research in STEM education and scientific research in the field of smart, and especially photoresponsive, nanobiomaterials for medicinal applications.
• Co-chair
  Young Jung No
  The University of Sydney, Australia
  Young Jung No
  The University of Sydney, Australia

  Dr Young No is a biomaterials engineer, Lecturer (US: Assistant Professor) and Deputy Head of School (Education) at the School of Biomedical Engineering at the University of Sydney, and also served as acting Associate Dean (Learning and Teaching) at the Faculty of Engineering in early 2023. Dr No was also awarded “40 under 40 Most Influential Asian-Australian for 2022” by the Asian-Australian Leadership Summit for his leadership in biomedical engineering programs at the University of Sydney, shaping the curriculum to be the most comprehensive in the southern hemisphere in terms of topics and areas covered to match the rapidly rising importance and relevance of biomedical engineering in the modern-day technological setting. His innovative and engaging teaching practices in his classes have been well-recognised, with multiple commendations received for his courses, teaching awards, and being featured in university videos for World Teachers’ Day in 2023. Dr No has also led and contributed significantly to biomedical engineering outreach, resulting in significantly increased interest in biomedical engineering amongst prospective students and subsequently increased number of students pursuing biomedical engineering at the University of Sydney for their professional careers. Dr No’s area of research is in the engineering and characterising novel synthetic bioactive materials for musculoskeletal applications, with primary focus on developing novel cements and ceramic composites. He has published 17 peer-reviewed journal articles, with all publications in journals ranked in the top 30% (Scimago Journal Rank) in the fields of materials science and biomedical engineering, including in high impact journals in the field, and has two published patents as primary co-inventor. His research on the synthetic biomaterials has been the subject of multiple successful grant applications, including the Australian Research Council Linkage Grant as well as other grants including the University of Sydney Commercial Development and Industry Partnership Fund, Australia–Germany Joint Research Co-operation Scheme (DAAD), and Harvard Mobility Scheme. YJN’s work has also been recognised for impact and won presentation awards in conferences including the Australia New Zealand Orthopaedic Research Society (ANZORS), and TERMIS-AP.
• Keynote Speaker
  12:20~12:45
  Johnna S. Temenoff
  Georgia Tech and Emory University, USA
  Johnna S. Temenoff
  Georgia Tech and Emory University, USA

  Dr. Johnna S. Temenoff is the Carol Ann and David D. Flanagan Professor the Coulter Department of Biomedical Engineering at Georgia Tech/Emory University. She is also currently the Director of the NSF Engineering Research Center in Cell Manufacturing Technologies (CMaT) and the Director of the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M). Scientifically, Dr. Temenoff is interested in scaling culture of therapeutic cells and tailoring the molecular interactions between glycosaminoglycans and proteins/cells for use in regenerative medicine applications. Her laboratory focuses primarily on promoting repair after injuries to the tissues of the shoulder, including cartilage, tendon, and muscle.
• Invited Speaker
  12:45~13:00
  Jurica Bauer
  Maastricht University, Netherlands
  Jurica Bauer
  Maastricht University, Netherlands

  Dr. Jurica Bauer graduated in chemistry from the University of Zagreb, Croatia, where he developed a passion for research and teaching. Having worked as medicinal chemist at GlaxoSmithKline for a few years, he moved to The Netherlands to pursue a PhD degree in the field of molecular motors and machines with Professor Feringa at the University of Groningen. As a postdoctoral researcher in the group of Professor Broer at the Eindhoven University of Technology and in collaboration with Philips, he developed a smart liquid-crystalline polymer coating for LEDs to fine-tune the properties of emitted light. In 2014 he was appointed Lecturer in Chemistry at the Inholland University of Applied Sciences in Amsterdam where he developed a new Polymer Chemistry minor and acted as graduation and internationalization coordinator. In 2020 he joined the MERLN Institute at the Maastricht University as Assistant Professor of Education to coordinate the design and development of a new undergraduate study program in the field of Regenerative Medicine and Technology. He is also involved in ongoing teaching and research activities within the institute. His interests include innovation and research in STEM education and scientific research in the field of smart, and especially photoresponsive, nanobiomaterials for medicinal applications.
• Invited Speaker
  13:00~13:15
  Young Jung No
  The University of Sydney, Australia
  Young Jung No
  The University of Sydney, Australia

  Dr Young No is a biomaterials engineer, Lecturer (US: Assistant Professor) and Deputy Head of School (Education) at the School of Biomedical Engineering at the University of Sydney, and also served as acting Associate Dean (Learning and Teaching) at the Faculty of Engineering in early 2023. Dr No was also awarded “40 under 40 Most Influential Asian-Australian for 2022” by the Asian-Australian Leadership Summit for his leadership in biomedical engineering programs at the University of Sydney, shaping the curriculum to be the most comprehensive in the southern hemisphere in terms of topics and areas covered to match the rapidly rising importance and relevance of biomedical engineering in the modern-day technological setting. His innovative and engaging teaching practices in his classes have been well-recognised, with multiple commendations received for his courses, teaching awards, and being featured in university videos for World Teachers’ Day in 2023. Dr No has also led and contributed significantly to biomedical engineering outreach, resulting in significantly increased interest in biomedical engineering amongst prospective students and subsequently increased number of students pursuing biomedical engineering at the University of Sydney for their professional careers. Dr No’s area of research is in the engineering and characterising novel synthetic bioactive materials for musculoskeletal applications, with primary focus on developing novel cements and ceramic composites. He has published 17 peer-reviewed journal articles, with all publications in journals ranked in the top 30% (Scimago Journal Rank) in the fields of materials science and biomedical engineering, including in high impact journals in the field, and has two published patents as primary co-inventor. His research on the synthetic biomaterials has been the subject of multiple successful grant applications, including the Australian Research Council Linkage Grant as well as other grants including the University of Sydney Commercial Development and Industry Partnership Fund, Australia–Germany Joint Research Co-operation Scheme (DAAD), and Harvard Mobility Scheme. YJN’s work has also been recognised for impact and won presentation awards in conferences including the Australia New Zealand Orthopaedic Research Society (ANZORS), and TERMIS-AP.
• Invited Speaker
  13:15~13:30
  Jeong-Kee Yoon
  Chung-Ang University, Korea, Republic of
  Jeong-Kee Yoon
  Chung-Ang University, Korea, Republic of

  Dr. Jeong-Kee Yoon is an associate professor in the Department of Systems Biotechnology at Chung-Ang University, Republic of Korea. He received his Ph.D. degree from Seoul National University, Republic of Korea in 2017, and worked as a postdoctoral researcher at Georgia Institute of Technology until 2021. His research interests are at the interface of regenerative medicine and biomedical engineering, primarily focused on vascular engineering using stem cells, engineered exosomes, and 3D cell culture methods for tissue regeneration and disease modeling. He has published 51 peer-reviewed articles, and is a co-inventor on two registered patents. In terms of education, he teaches Organic Chemistry, Biomaterials, and Biomedical Engineering to undergraduates of non-engineering majors, and Tissue Engineering and Regenerative Medicine to graduate students. He has been selected twice (in 2022 and 2023) as a Teacher of Excellence at Chung-Ang University based on surveys completed by 70-80 students per class.

  The field of biomaterials is a highly interdisciplinary field where materials science and engineering meet chemistry, biology, medicine and entrepreneurship. The advancement of this complex field therefore necessitates research collaborations from various experts. Pushing the field forward, however, also implies educating the future generations of scientists and engineers in a better way than how we were once trained. Given the complexity and interdisciplinarity of the field, it is no secret that we meet many challenges in our attempts to transfer our knowledge, skills and experience to our students. In order to be able to improve our education in this field, it is imperative that we share our teaching practices and ideas in biomaterials.
 In this symposium we wish to invite experts and educators in the field of biomaterials to share their observations, challenges (and solutions), practices, initiatives, and research in the education relating to biomaterials. Contributions at any level are welcome, ranging from simple tips & tricks used to activate students in lessons, or new and original experiments for practicals, to new courses and even programs. The intention is not only to exchange best practices and learn from each other during this conference but also to create a network in which sharing ideas and experiences would also lead to new initiatives and collaborations on the education in the field of biomaterials.

Keywrod : Education

• Organizer
  Seung-Woo Cho
  Yonsei University, Korea, Republic of
• Chair
  Hua Ai
  West China Hospital, Sichuan University, China
• Co-chair
  Nicholas Dunne
  Dublin City University, Ireland
  Nicholas Dunne
  Dublin City University, Ireland

  Nicholas Dunne is the Full Professor of Biomaterials Engineering and holds Executive Directorship for the Medical Engineering Research Centre and Biodesign Europe at Dublin City University (Ireland). Prof Dunne's research programme lies at the interface of materials science, engineering and biology, and his group focuses in the development of stratified approaches for the design, manufacture and characterisation of drug-biomaterial combination medical devices for efficacious hard and soft tissue repair and regeneration. This work spans fundamental mechanisms at the host/material interface as well as translational research to target non-union bone defects, bone metastases and chronic wounds. This research programme has been developed via a strong, interdisciplinary research programme complimented with over-arching international research institute and industry collaborations.
• Speaker
  12:20~12:35
  Joachim Kohn
  Rutgers University/IUSBSE, USA
  Presentation Title : CRITICAL TURNING POINTS IN BIOMATERIALS RESEARCH FROM 1980 TO TODAY
  Joachim Kohn
  Rutgers University/IUSBSE, USA

  Joachim Kohn, PhD, FBSE is a national leader in the field of biomaterials science. As founding director of the New Jersey Center for Biomaterials (NJCBM) for 22 years and as Head of the Laboratory for Biomaterials Research at Rutgers, Prof. Kohn has made seminal contributions to the design and commercialization of new biomaterials for regenerative medicine, tissue engineering and drug delivery. He pioneered the use of combinatorial and computational methods for the optimization of polymer properties for use in medical implants (including a coronary stent and an antimicrobial device to prevent infections in pacemaker patients). These implants are being used by over one million patients and are currently approved in 46 countries. As a translational scientist, Prof Kohn has 78 issued US Patents on novel biomaterials and seven companies have licensed his technologies. He is the scientific founder of three spin-off companies. Dr Kohn retired from Rutgers in 2020 and remains active in research, entrepreneurship and the biomaterials community. He was elected President of the International Union of Societies for Biomaterials Science and Engineering in 2020. Selected Recent Honors and Awards 2022 Recipient of the Award for Distinguished Contribution in Advancement of Biomaterials Science, given by the Japanese Society for Biomaterials 2022 Recipient of the International Award by the European Society for Biomaterials 2020 Recipient of the National Award in Applied Polymer Science by the American Chemical Society. 2019 Recipient of the 2019 Society for Biomaterials Founders Award for life-time achievements in biomaterials science. 2018 Recipient of the 2018 Healthcare Heroes Award for outstanding contributions to the advancement of biomaterials-based therapies. 2017 Recipient of the 2017 Thomas Alva Edison Patent Award for best patent in biomaterials in New Jersey presented by the Research and Development Council of New Jersey.
• Speaker
  12:35~12:50
  Ana Paula Pego
  i3S / INEB - University of Porto, Portugal
  Presentation Title : Futuring Neurosciences with Biomaterials
  Ana Paula Pego
  i3S / INEB - University of Porto, Portugal

  Ana Paula Pêgo got her Ph.D. in Polymer Chemistry and Biomaterials from the University of Twente, the Netherlands, in 2002. In 2003 she moved to INEB – Instituto de Engenharia Biomédica, where she became a Principal Investigator in 2012. In 2015, INEB joined the i3S – Instituto de Investigação e Inovação em Saúde (Universidade do Porto), where Ana Paula Pêgo leads the nanoBiomaterials for Targeted Therapies (nBTT) Group. By using nanomedicine strategies the nBTT Group, aims at providing in situ and in a targeted manner the required signals to promote nervous tissue regeneration. The research on new biomaterials for application in neurosciences includes the development of new polymers for the design of alternative vectors to viruses for efficient nucleic acid delivery, the preparation of nerve grafts for spinal cord injury treatment and the design of brain tissue engineered platforms. Societal and ethical issues that concern Regenerative Medicine and NanoMedicine are also topics in which Ana Paula Pêgo is involved. She has been appointed the Scientific Director of the Bioimaging Centre for Biomaterials and Regenerative Therapies of INEB and she is an Invited Associate Professor at the Instituto de Ciências Biomédicas Abel Salazar (ICBAS) of the University of Porto. Currently Ana Paula Pêgo is a member of the Board of Directors of i3S, being the Head of Strategy & Creation of Value Unit, serves as an Associate Editor of Biomaterials (Elsevier journal) and is part of the Board of Reviewing Editors of Science (AAAS). Ana Paula Pêgo served two terms in the European Society for Biomaterials (ESB) Council, being the ESB Council Secretary from 2017-2021 and the ESB President from 2021-2023, being now the ESB past President.
• Speaker
  12:50~13:05
  Diego Mantovani
  Laval University, Canada
  Presentation Title : A Career in Research: Still Opportune? An introspective journey into the meaning of becoming a scientist in the 21th century
  Diego Mantovani
  Laval University, Canada

  Professor in biomaterials, scientist in regenerative medicine, holder of the Canada Research Chair Tieur I in biomaterials and bioengineering for the innovation in surgery, Diego Mantovani is en expert in nanocoatings, biodegradable metals and 3D cell culture for advanced in vitro tests alternative to in vivo. With his team, he carried out R&D&I projects often in collaboration with companies to unravel how sciences and engineering can improve the patient quality of life of Humans, and to develop new processes for improving the clinical performances of commercial devices, as well as exploring new strategies for tomorrow's clinical therapies. Focus is on cardiac, peripheral, cerebral, dental and parenchymal tissue. The Lab is based at ULaval, in the beatiful nordic city of Quebec, labelled UNESCO treasure, in the French-living part of Canada. He was elected Fellow of the International Union of Societies of Biomaterials since 2012, of the American Society for Materials Intl since 2016, the American Institute of Medical Biological Engineering since 2019, and of the Canadian Academy of Engineering since 2020. He was executive Co-Chair of the 10th World Biomaterials Congress, held in Montréal, Canada, in 2016, May.

This luncheon session will provide a unique opportunity for students and young scientists to interact with experienced mentors, establishing a connection between the extensive historical background of biomaterials research, its current state, and the promising prospects in the future. During this session, a distinguished group of mentors will share their knowledge and perspectives on the historical turning points that have established the foundation of biomaterials research with highlighting cutting-edge innovations and interdisciplinary collaborations. Participants will have the chance to connect with mentors who have played pivotal roles in shaping the field, gaining valuable guidance on navigating challenges and capitalizing on opportunities. Overall, this session not only provides a comprehensive overview of the past and present of biomaterials research but also cultivates mentorship relationships that are instrumental in guiding the next generation of scientists toward a promising future in the field of biomaterials.

• Organizer
  Sukmo Kang
  Biotoxtech.Co.Ltd, Korea, Republic of
  Sukmo Kang
  Biotoxtech.Co.Ltd, Korea, Republic of

  Sukmo Kang completed his B.S. and M.S. degrees in Veterinary Science at Seoul National University and earned a Ph.D. in Nanomedicine from KAIST. He currently oversees business development and research planning at Biotoxtech group (Biotoxtech, Keyfonbio, and Keyprime Research). As the CTO of Keyfronbio, he supervises bioanalysis and efficacy testing services. His prior work included research on nanomaterial-based vaccine engineering and the development of tailored therapeutic regimes. Kang's extensive experience across various research domains provides valuable insights into candidate development, non-clinical development planning, TPP development, risk assessment, and CMC development for new therapeutic modalities.
• Chair
  Sukmo Kang
  Biotoxtech.Co.Ltd, Korea, Republic of
  Sukmo Kang
  Biotoxtech.Co.Ltd, Korea, Republic of

  Sukmo Kang completed his B.S. and M.S. degrees in Veterinary Science at Seoul National University and earned a Ph.D. in Nanomedicine from KAIST. He currently oversees business development and research planning at Biotoxtech group (Biotoxtech, Keyfonbio, and Keyprime Research). As the CTO of Keyfronbio, he supervises bioanalysis and efficacy testing services. His prior work included research on nanomaterial-based vaccine engineering and the development of tailored therapeutic regimes. Kang's extensive experience across various research domains provides valuable insights into candidate development, non-clinical development planning, TPP development, risk assessment, and CMC development for new therapeutic modalities.
• Speaker
  12:20~12:40
  Mark van Eldijk
  Ardena Oss BV, Netherlands
  Presentation Title : Process & Specification Development for Nanomedicine Manufacture
  Mark van Eldijk
  Ardena Oss BV, Netherlands

  Mark van Eldijk is the Business Unit Director of Nanomedicines at Ardena. He obtained a PhD in Bio-organic Chemistry from Radboud University Nijmegen, where he worked on the design and preparation of biopolymer-based nanoparticles. Subsequently, Mark worked at California Institute of Technology as a postdoctoral research fellow. In total he has published more than 20 papers in peer-reviewed journals. Mark joined Ardena in 2016 as a scientist and project leader, and then moved into business development. In his current role as Business Unit Director, Mark leads a dynamic team dedicated to the development and manufacture of innovative nanomedicine products, including lipid-based nanoparticles, polymeric nanoparticles and metal/metal oxide nanoparticles conjugated or loaded with a diverse array of therapeutic payloads, such as cytotoxics, oligonucleotides, mRNA, peptides, and proteins.
• Speaker
  12:40~13:00
  Kyung Won Kim
  Department of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of
  Presentation Title : Clinical Developmet of Nanoparticle based-Contrasting Agents
  Kyung Won Kim
  Department of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of

  Kyung Won Kim, MD. PhD. is an associate professor in Radiology Department of Asan Medical Center as well as a CEO in Trial Informatics. He completed his B.S. and Ph.D degrees in Medicine at Seoul National University College of Medicine. He was trained in Dana-Farber Cancer Institute, Harvard Medical School as a clinical fellow. For over 10 years, imaging research in both non-clinical and clinical trials has been my major focus in the development of new drugs and artificial intelligence. He is a founder of Asan Image Metrics, the first Imaging Core Lab for clinical trials in Korea, which has been established and has participated in over 70 new drug development projects. He received an award from the Minister of Health and Welfare in 2022. In 2021, he found a new company called Trial Informatics, which develops digital platforms for clinical trials and provides medical monitoring and digital transformation services. Currently, he has published 253 papers in SCI journals (with about 100 as the main author) and is actively engaged in academic and writing activities. The author also holds 15 patent applications and 13 registered patents, some of which have been commercialized through technology transfer.
• Speaker
  13:00~13:20
  Sukmo Kang
  Biotoxtech.Co.Ltd, Korea, Republic of
  Presentation Title : Preparation and Consideration for Nonclinical study of Nanomedicines
  Sukmo Kang
  Biotoxtech.Co.Ltd, Korea, Republic of

  Sukmo Kang completed his B.S. and M.S. degrees in Veterinary Science at Seoul National University and earned a Ph.D. in Nanomedicine from KAIST. He currently oversees business development and research planning at Biotoxtech group (Biotoxtech, Keyfonbio, and Keyprime Research). As the CTO of Keyfronbio, he supervises bioanalysis and efficacy testing services. His prior work included research on nanomaterial-based vaccine engineering and the development of tailored therapeutic regimes. Kang's extensive experience across various research domains provides valuable insights into candidate development, non-clinical development planning, TPP development, risk assessment, and CMC development for new therapeutic modalities.
• Speaker
  13:20~13:40
  Seho Kweon
  College of Pharmacy, Chonnam National University, Korea, Republic of
  Presentation Title : Strategy for the oral formulation of biomaterials to apply in clinics
  Seho Kweon
  College of Pharmacy, Chonnam National University, Korea, Republic of

  Seho Kweon is an assistant Professor at the College of Pharmacy at Chonnam National University in South Korea. With a Ph.D. from Seoul National University and having conducted postdoctoral research at Mokpo National University, he possesses extensive expertise. Before joining academia, he contributed significantly to drug development and regulatory processes at Hanmi Pharmaceuticals Co. Ltd. His current research focuses on developing computational pharmaceutics for biologics, peptide delivery systems for diabetes and obesity, and applying mathematical models to cancer treatment for translational science.

The workshop is designed to explore the practical journey of translating laboratory-developed technologies into commercial applications. We will delve into recent developments in nanomedicine, emphasizing the crucial bridge between preclinical and clinical phases. Attendees can expect insights into navigating the transition, including considerations for non-clinical studies, the clinical development and optimizing manufacturing processes. This workshop is tailored for professionals in nanomedicine and related fields, offering valuable insights for all levels of expertise. It will highlight the pivotal role of nanomedicine in advancing healthcare through real-world applications.

• Organizer
  Brittany Taylor
  University of Florida, USA
• Chair
  Brittany Taylor
  Department of Biomedical Engineering, University of Florida, USA
• Co-chair
  Erika Moore
  Department of Material Science, University of Florida, USA
• Speaker
  12:20~12:32
  Chiara Ghezzi
  Department of Biomedical Engineering, University of Massachusetts Lowell, USA
  Chiara Ghezzi
  Department of Biomedical Engineering, University of Massachusetts Lowell, USA

  The focus of my research is on understanding how multicellular responses are affected by the native microenvironment in order to design and engineer natural polymers to support the investigation of these processes in vitro and in vivo. My research liaises engineering biopolymer structure/function properties with advanced biofabrication techniques to develop three-dimensional tissue models, by combining physiological architecture, physical stimuli, and native microstructure to recapitulate healthy and diseased tissue states. The impact of these approaches will be to further guide and educate biopolymer material designs towards needs in regenerative medicine. These systems focus on studying host responses to direct pathogen interactions and, ultimately, provide successful long-term three-dimensional tissue constructs with functionality both in vitro and in vivo.
• Speaker
  12:32~12:44
  Jay Patel
  Department of Orthopaedics, Emory University School of Medicine, USA
  Jay Patel
  Department of Orthopaedics, Emory University School of Medicine, USA

  Dr. Jay Patel is an Assistant Professor in the Department of Orthopaedics at Emory and a Health Science Specialist at the Atlanta VA Medical Center. Dr. Patel joined the faculty at Emory in September 2020, and his program focuses on the repair and regeneration of musculoskeletal tissues (e.g., cartilage, meniscus), with an emphasis on using micro-scale findings to drive macro-scale therapies. His lab uses a combination of biomechanics, biomaterials, mechano-biology, in vitro systems, and functional in vivo models to motivate, design, develop, and evaluate novel treatments and therapeutics for musculoskeletal injuries. Dr. Patel received his Bachelor’s in Bioengineering from Rice University and his PhD in Biomedical Engineering from Rutgers University. While at Rutgers, his research focused on a novel meniscus replacement scaffold, evaluating it in long-term large-animal models and human cadaveric biomechanical simulations. Dr. Patel then pursued his postdoctoral training at the University of Pennsylvania in the Department of Orthopaedic Surgery, working on a variety of cartilage tissue engineering and mechano-biology projects. Dr. Patel has published over 30 manuscripts, many in leading orthopaedic and tissue engineering journals, and has presented at numerous international conference meetings. Furthermore, he has won several prestigious awards, including the Excellence in Research Award (2018) from the American Orthopaedic Society for Sports Medicine and the Cum Laude Award (2019) from the International Cartilage Repair Society. Moreover, both his graduate and postdoctoral work resulted in pending patent applications, and the formation of startup companies with active small-business funding, demonstrating his ultimate goal of translating these approaches to the clinic. Currently, Dr. Patel has a Career Development Award through the Department of Veterans Affairs, and is actively expanding his program to interface between basic science, engineering, and the clinic.
• Speaker
  12:44~12:56
  Bethany Almeida
  Chemical and Biomolecular Engineering, Clarkson University, USA
  Bethany Almeida
  Chemical and Biomolecular Engineering, Clarkson University, USA

  Dr. Bethany Almeida is an Assistant Professor in the Department of Chemical and Biomolecular Engineering at Clarkson University. Dr. Almeida’s research focuses on engineering advanced, functional biomaterials to modulate stem cell behavior with applications in tissue engineering/regenerative medicine, wound healing, and immunoengineering. Dr. Almeida is also passionate about science communication and K-12 outreach. Dr. Almeida is the recipient of several national and university honors and awards, including a 2020 BMES Career Development Award and being named a 2020 Rising Star in Engineering in Health by Columbia University. Prior to joining Clarkson University, Dr. Almeida was an American Society for Engineering Education Postdoctoral Fellow in the Center for Bio/molecular Science and Engineering at the US Naval Research Laboratory. She received her Ph.D. in Biomedical Engineering from Brown University in 2019 and her Bachelor’s of Science at Worcester Polytechnic Institute in 2013 with majors in Biomedical Engineering and Professional Writing.

  The purpose of this workshop is to provide participants, ranging from upper-level graduate students, postdoctoral trainees, and junior faculty, with tools and strategies to accomplish their academic career goals. The workshop will cover topics including: how to successfully fund your research, effectively manage your team, and establish and maintain an institutional and international scientific identity. We will discuss grant writing strategies, responsible spending of your start-up funds, setting lab culture and expectations, networking, and other nuances that come along with getting started in your faculty career.
  The workshop will feature junior faculty panelists who can share their diverse perspectives from their experiences setting up labs at institutions of varying sizes, research-levels, and locations. We will intentionally include international faculty to represent international perspectives. Following the panel, we will lead the participants in networking challenges as well as peer discussions, group sessions, and activities to gain additional insights from faculty and peers alike.
  Lastly, we will provide participants with an electronic toolkit which will include the information disseminated in the workshop and templates, such as lab expectation documents. This workshop will equip #NewPIs in biomaterial research with the foundation to become future leaders in the field.

• Invited Speaker
  12:20~13:10
  Sung-Tae Kim
  Seoul national university School of Dentistry, Korea, Republic of
  Presentation Title : Collagen Matrix(Collagen Graft 2) vs Membrane
  Sung-Tae Kim
  Seoul national university School of Dentistry, Korea, Republic of

  Dentist, Periodontist, Prosthodontist, Tenured professor in Seoul National University School of Dentistry and Seoul National University Dental Hospital

Collagen matrix (Collagen graft 2) vs Collagen membrane

‘Gingival augmentation using collagen matrix’, which was recognized as a new medical technology from Korean Ministry of Health and Welfare in 2023 has been spreading widely in the Korean dental community attracting attention as a simple yet effective periodontal plastic surgery.
This collagen matrix has been used in Europe and the United States for periodontal plastic surgery for a long time, and its effectiveness has been proven in previous studies. Recently, various indications other than periodontal plastic surgery have been introduced in Korea; 1) indications for alveolar ridge preservation, and 2) indications for ridge augmentation instead of barrier membranes. A recent experiment conducted at the Department of Periodontology at Seoul National University showed that collagen matrix was superior to barrier membranes in ridge preservation procedure (Sci Rep. 2024 Jan 2;14(1):163).
In this lecture, clinical cases with various indications, and supporting studies about collagen matrix (Collagen graft 2) will be discussed.

Keywrod : Dentium

• Organizer
  Joo Hee (Elise) Kim
  Ajou University, Korea, Republic of
• Chair
  Joo Hee (Elise) Kim
  Ajou University, Korea, Republic of
• Co-chair
  James Moon
  University of Michigan, Ann Arbor, USA
  James Moon
  University of Michigan, Ann Arbor, USA

  Dr. James Moon is John Gideon Searle Professor in the Department of Pharmaceutical Sciences, Biomedical Engineering, and Chemical Engineering at the University of Michigan, Ann Arbor. His interdisciplinary research program aims to develop novel biomaterials-based strategies to advance fundamental understanding of the immune system, with the ultimate goal of improving patients’ lives with effective vaccines and immunotherapies. Dr. Moon has published over 120 research articles, including those published in Nature Materials, Nature Medicine, Nature Nanotechnology, Nature Biomedical Engineering, Nature Reviews Materials, and Science Translational Medicine. He has over 20 pending/approved U.S. and international patent applications, and his novel nano-vaccine delivery technologies have led to 3 new start-up companies (EVOQ Therapeutics, Saros Therapeutics, and Elicio Therapeutics). Dr. Moon is a fellow of BMES, AIBME, and CRS, and his contributions to the field has been recognized with numerous awards, including NSF CAREER Award and Samyang CRS Award. Dr. Moon received his bachelor’s degree from the University of California, Berkeley (2002), and his Ph.D. from Rice University (2008), and he completed his postdoctoral training at MIT. He joined the faculty of the University of Michigan in 2012.
• Invited Speaker
  12:20~12:50
  James Wabby
  Regulatory Affairs (CoE), AbbVie, Inc, USA
  Presentation Title : Innovative Products: Regulatory Pathways
  James Wabby
  Regulatory Affairs (CoE), AbbVie, Inc, USA

  James is responsible for leading global regulatory affairs for AbbVie’s device and medicinal/device delivery portfolio providing the vision for the future of device at AbbVie and in the broader industry. James has 22 years of experience in increasing regulatory compliance and regulatory affairs responsibilities within the GxP regulated environment pertaining to Medical Devices, Medicinal Delivery Platforms, Companion Diagnostics, Digital Medicine, and Combination Product areas. He regularly provides AbbVie therapeutic franchise units regulatory counsel and strategy to all aspects within the quality management system and regulatory affairs. James is an internationally recognized leader as he is a member of various regulatory/quality work groups and is a speaker and keynote at various regulatory symposia. In addition, he is the Chair of the DIA Combination Products Committee, Chair of the ISPE Combination Products (CoP), and a moderator for various global regulatory panel discussions. James holds a BSc. in Biology from Duquesne University, MHMS in Health Law and Policy from Duquesne University, Certificate in Health Law and Life Science Regulatory Compliance from Seton Hall University Law School - Center for Health & Pharmaceutical Law, and Certificate, RAPS Executive Development Program from Northwestern University - Kellogg School of Management.
• Invited Speaker
  12:50~13:20
  Takahiro Ochiya
  Tokyo Medical University, Japan
  Presentation Title : Regulatory aspect of extracellular vesicles for regenerative medicine
  Takahiro Ochiya
  Tokyo Medical University, Japan

  Dr. Takahiro Ochiya was a Chief of Division of Molecular and Cellular Medicine at the National Cancer Center Research Institute, Tokyo since 2010 and he is currently appointed as professor of Tokyo Medical University (since 2018). After he got Ph.D. in 1988 in Osaka University and then went to do a post-doc at La Jolla Cancer Research (SF Burnham Institute for Medical Research), CA, USA. Dr. Ochiya’s lab focuses the development of novel animal models, methods, and strategies to study cancer development and metastasis. Especially, current focuses are siRNA- and microRNA-based therapy against cancer stem cells. Dr. Ochiya is a leading scientist in extracellular vesicles research in cancer area and carries president of Japanese Society of Extracellular Vesicles (JSEV) since 2014. He is also carrying as ISEV board member (education committee) since 2020. Dr. Ochiya awarded as Highly Cited Researchers in the Web of Science in 2019~ 2023.

• Organizer
  Seung-Woo Cho
  Yonsei University, Korea, Republic of
• Chair
  Won Jong Kim
  Pohang University of Science and Technology (POSTECH), Korea, Republic of
• Co-chair
  Ines Goncalves
  i3S - Institute for Research and Innovation in Health, Portugal
  Ines Goncalves
  i3S - Institute for Research and Innovation in Health, Portugal

  Inês C. Gonçalves is Principal Investigator at i3S – Instituto de Investigação e Inovação em Saúde, and Leader of the Advanced Graphene Biomaterials Group. She is co-founder of the Start-Up GOTech Antimicrobial, and board member of the Iberian Society of Biomechanics and Biomaterials (SIBB). From 2010 to 2021 she was invited professor at University of Porto (FEUP and at ICBAS), teaching in Bioengineering Masters. IG is a Microbiologist with PhD in Biomedical Engineering. She focuses on the development of graphene biomaterials and medical devices for antimicrobial and cardiovascular applications, ranging from fundamental science to translational applications. She has been involved in 20 research projects (12 as principal investigator), in the organization of 21 national/international conferences (10 as scientific committee and 11 as organizing committee) and participates in initiatives at i3S that aim to provide primary school children a first contact with science. Inês C. Gonçalves is the author of 42 papers in peer reviewed international journals (H-index 23, 1827 citations; source: Scopus ID 7006107771) and 4 book chapters, and has 5 filled patents (1 already granted). Her work was presented as over 70 oral communications and over 50 posters in international conferences. She has supervised/co-supervised 4 Post-Docs (2 ongoing), 12 research assistants (1 ongoing), 5 PhD students (2 ongoing) and 15 MSc students (3 ongoing). Her work has been recognized with several national and international awards, including "Pulido Valente Science Prize”, the "Medal of Honor L'Oreal for Women in Science", and recently the “Innovator Award” from Wellcome Trust.
• Speaker
  12:20~12:35
  Andrés J. García
  Georgia Institute of Technology, USA
  Presentation Title : Moving Research from the Lab to Startups
  Andrés J. García
  Georgia Institute of Technology, USA

  Andrés J. García is the Executive Director of the Petit Institute for Bioengineering and Bioscience and Regents’ Professor at the Georgia Institute of Technology. Dr. García’s research program integrates innovative engineering, materials science, and cell biology concepts and technologies to create cell-instructive biomaterials for regenerative medicine and generate new knowledge in mechanobiology. This cross-disciplinary effort has resulted in new biomaterial platforms that elicit targeted cellular responses and tissue repair in various biomedical applications, innovative technologies to study and exploit cell adhesive interactions, and new mechanistic insights into the interplay of mechanics and cell biology. In addition, his research has generated intellectual property and licensing agreements with start-up and multi-national companies. He is a co-founder of 3 start-up companies (CellectCell, CorAmi Therapeutics, iTolerance). He has received several distinctions, including the NSF CAREER Award; the Young Investigator Award, the Clemson Award for Basic Science, and the Founders Award from the Society for Biomaterials; the International Award from the European Society for Biomaterials; and Georgia Tech’s Outstanding Interdisciplinary Activities Award and the Class of 1934 Distinguished Professor Award. He is an elected Fellow of Biomaterials Science and Engineering (by the International Union of Societies of Biomaterials Science and Engineering), Fellow of the American Association for the Advancement of Science, Fellow of the American Society of Mechanical Engineers, and Fellow of the American Institute for Medical and Biological Engineering. He served as President for the Society for Biomaterials in 2018-2019. He is an elected member of the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors.
• Speaker
  12:35~12:50
  Nan Huang
  Southwest Jiaotong University, China
  Presentation Title : From basic research to clinic application - a innovation story about a novel cardiovascular stent
  Nan Huang
  Southwest Jiaotong University, China

  Nan Huang is professor of Biomaterials at the Department of Materials Sciences and Engineering of Southwest Jiaotong University, China. He leads a group specialized in cardiovascular biomaterials, surface modification and implantable and interventional devices. He has published over 1000 papers in international journals. And obtained over 100 patents. One kind of stent was developed by his team with both excellent anticoagulation and anti-restenosis properties. Until now about 400 thousands of patients have been accepted the intervention with this stent in clinic in China and the complications was significant lower than other kinds of stnets. Prof. Nan Huang has been the Fellow of the International Union of Societies for Biomaterials Science & Engineering since 2008, and is the Chairman of the International Committee of the International Symposium on surfaces and the Interfaces of Biomaterials since 2007.
• Speaker
  12:50~13:05
  Matteo Santin
  University of Brighton, United Kingdom
  Presentation Title : Technopreneurship: Building your future with knowledge and know-how
  Matteo Santin
  University of Brighton, United Kingdom

  Prof Matteo Santin is Professor of Tissue Regeneration at the School of Applied Sciences, University of Brighton, UK, and the Director of the Brighton Centre for Regenerative Medicine and Devices. His career in biomedical research and teaching started in 1989 and it has been marked by significant achievements that were internationally recognised in 2005 by the European Society for Biomaterials who conferred him the Jean Leary Award, elected him as a member of the board (2009-2013) and as the President of the Society (2013-2017). He is the founder and director of 2 start-up companies with a mission in biomaterials, Brighton Wound Care Ltd and Tissue Click Ltd. His scientific interests include natural biomaterials, synthetic biomimetic nano-structured biomaterials able to control tissue regeneration and biosensing. He has developed in vitro clinically-reflective models for the testing of nanomedicines, biomaterials and tissue engineering constructs. He has published over 100 peer-reviewed papers, over 200 presentations at international conferences, filed 11 patents applications and unveiled for the first time the biochemical and cellular mechanisms of inflammatory response to silk fibroin, new cellular mechanisms leading to the failure of cardiovascular stents and the tissue regeneration potential of novel soybean-based biomaterials and biomimetic dendrimers (i.e. hyperbranched molecules able to control cell functions and tissue regeneration).

The purpose of this luncheon session is to facilitate the exchange of ideas among young researchers about effective integration of academic research with practical applications in the commercial sector. This event has a lineup of speakers that have successfully transformed their academic endeavors into tangible products or established startup companies. Their perspectives, challenges, and insights will be disseminated among emerging and young scientists. Participants can expect stimulating discussion regarding practical aspects of converting scientific discoveries into commercially viable innovations, encompassing topics such as intellectual property, funding strategies, and collaboration with industry partners. This session serves as a forum for both a knowledge-sharing event and as a source of inspiration for the next generation of scientists, motivating them to foresee the broader impact of their study and to consider the commercial potential of their work.